Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
EXPERT OPINION ON PHARMACOTHERAPY(2009)
Abstract
Plaque-type psoriasis is a chronic and immune-mediated skin disease affecting similar to 1 - 3% of the Caucasian population. Most cases are of mild or moderate severity and benefit from local treatment that represents the mainstay therapy. Topical corticosteroids and vitamin D-3 analogues remain the option of choice. optimization of these treatments is made by the combination of calcipotriene and betamethasone dipropionate. This formulation combines the keratinocyte differentiation and antiproliferative action of the vitamin D-3 analogues with the anti-inflammatory effect of steroids enhancing effectiveness while reducing the side-effect profile of the single topical agent. In this article, we highlight the advantages of the association of calcipotriene and betamethasone in the treatment of localized plaque-type, scalp and nail psoriasis.
MoreTranslated text
Key words
betamethasone dipropionate,calcipotriene,nail psoriasis,plaque-type psoriasis,two-compound product
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined